Schedule 13D ownership disclosure

ITEOS THERAPEUTICS INC

Common Stock · CUSIP: 46565G104

Event date: 2025-05-15

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • EcoR1 Capital, LLCReported CIK 0001587114

    Shares: 10,688,978.00 · Class: 27.9%

  • Oleg NodelmanReported CIK 0001454385

    Shares: 10,688,978.00 · Class: 27.9%

  • EcoR1 Capital Fund Qualified, L.P.Reported CIK 0001598292

    Shares: 10,020,210.00 · Class: 26.2%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000935836-25-000388
Form type
SCHEDULE 13D
Filer
EcoR1 Capital, LLC
CIK
CIK 1587114
Filed
May 16, 2025
Reporting period
May 15, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub